Nachrichten zur Eli Lilly & Co. Aktie

Eli Lilly: Obesity Drug Development To Go Beyond That Of Zepbound

…

Weight-Loss Drug Craze Boosts $80 Billion Lilly Endowment to Largest in US

The endowment started by the founding family of drugmaker Eli Lilly saw its assets surge to $80 billion at the end of 2024, passing Bill…

Trumps EO Targets Big Pharma Stocks like Eli Lilly

Trumps order looking to cut prescription drug prices is bearish for drug stocks at the surface, but is the worst…

2 Monster Stocks in the Making to Buy Now and Hold for 10 Years

Investing in promising companies before their stock prices soar is an excellent recipe for earning life-changing returns. However, with hundreds…

The Zacks Analyst Blog Highlights J&J, Eli Lilly, Pfizer, Merck, Amgen

J&J, Eli Lilly, Pfizer, Merck, Amgen are included in this Analyst Blog.…

Fox One, SoftBank delays investment, Zepbound weight loss

Yahoo Finance host Brad Smith tracks todays top moving stocks and biggest market stories in this Market Minute, including Foxs (FOX,…

Eli Lilly stock sinks as pharma misses out on the market rally

Pharma companies were mostly left out of the stock market’s broader rally Monday morning on the news that President Donald…

Stocks making the biggest moves premarket: Nvidia, Best Buy, Eli Lilly, Tesla, Amazon and more

These are the stocks posting the largest moves in premarket trading.…

Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy in obesity drug trial

Eli Lilly and Co (NYSE:LLY)’s weight loss drug Zepbound (tirzepatide) has shown superior results compared to Novo Nordisk (NYSE:NVO)’s Wegovy…

Billionaire Chase Coleman Has 68% of His $24.5 Billion Portfolio Invested in 10 Stocks. Heres the Best of the Bunch.

At age 49, Chase Coleman III is relatively young to be one of the wealthiest people on the planet. But…

Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy in weight loss trial By Investing.com

Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy in weight loss trial…

Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy for weight loss in trial By Reuters

Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy for weight loss in trial…

President Trump Just Announced Terrible News for Eli Lilly Investors

President Donald Trumps second term in office has been challenging for investors, at least so far. Trump imposed sweeping tariffs…

Prediction: These 2 Stocks Will Join the Trillion-Dollar Club by 2030

There is a small, exclusive group of companies with market caps above $1 trillion. Over time, more corporations will join…

Eli Lilly investing $250 million in research at Purdue University

Its one of the largest such agreements in the country.…

Eli Lilly expands Purdue University partnership with $250M investment

Eli Lilly is investing more in its home state of Indiana,…

4 No-Brainer Stocks to Buy Right Now

Market volatility and near-term uncertainty can be challenging to deal with these days -- or at any time. However, even…

One of the Largest Teacher Pension Funds in the U.S. Sold Nvidia, Tesla, and Apple and Piled Into a Popular Pharmaceutical Stock Up 395% Over the Last 5 Years

With the second quarter of 2025 now over a month old, many investment funds will soon begin disclosing what stocks…

Post-Earnings Dip: Why This Beaten-Down Stock Is a No-Brainer Buy

There is plenty of movement in equity markets during earnings season, but from a fundamental standpoint, investment theses seldom change.…

Down Nearly 20%: Should You Buy the Dip on Eli Lilly? @themotleyfool #stocks $LLY $CVS $RHHBY $NVO $VKTX $ZLDP.F

…

U.S. judge supports FDA decision on Eli Lilly’s weight loss drugs By Investing.com

U.S. judge supports FDA decision on Eli Lilly’s weight loss drugs…

Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped

Good news for Hims & Hers stock spooks Lilly and Novo investors.…

Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped @themotleyfool #stocks $HIMS $NVO $LLY

Good news for Hims & Hers stock spooks Lilly and Novo investors.…

Eli Lilly Stock Slips on Outlook. Is It Time to Buy the Dip?

Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker lowered its full-year profit outlook, and a potential headwind to…

Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped

Investors are buying Hims & Hers Health (NYSE: HIMS) stock hand over fist after the mail-order drugs company reported an…

3 No-Brainer Stocks to Buy in May

Any time is a great time to buy stocks -- if you pick the right stocks. Thats true even in…

Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?

Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Stock market volatility or even economic downturns…

Eli Lillys Meltdown Triggers Near Doubling Upside Potential - Reiterate Buy

…

Eli Lilly: Dont Overthink This Buying Opportunity

…

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

GLP-1 drug prices are falling. Thats good news for patients, but perhaps not such good news for pharmaceutical stock investors.…

Is Novo Nordisk Stock a Buy?

For years, Denmark-based Novo Nordisk (NYSE: NVO) was a fairly traditional develop-and-market pharmaceutical company that escaped notice by many investors.…

Novo Nordisk Forges Multiple Partnerships To Sell Obesity Drug Wegovy At A Discount

The pharmaceutical firm Novo Nordisk is pursuing a multi-pronged strategy to regain market share that it has lost to Eli…

Eli Lillys earnings beat is clouded by Novo news. What it means for investors

We suspect the CVS Health change, which goes into effect on July 1, could put a temporary overhang on Eli…

CVS Health Excludes Zepbound: Why Eli Lillys 11%+ Drop Looks Overdone

…

Stocks making the biggest moves midday: Meta Platforms, Qualcomm, Eli Lilly, CVS Health and more

These are the stocks posting the largest moves in midday trading.…

Why Eli Lilly Stock Is Sinking Today

Shares of Eli Lilly (NYSE: LLY) are sliding on Thursday. The stock lost 8.3% as of 12:21 p.m. ET. The…

5 stocks to watch on Thursday: AAPL, ABNB, MA, LLY and MCD (MA:NYSE)

Apple (AAPL), Airbnb (ABNB), Mastercard (MA), Eli Lilly (LLY), and McDonalds (MCD) are the stocks to watch on Thursday. Read…

Eli Lilly CEO says company can help respond to national security concerns around essential drugs as tariffs loom

Ricks said reshoring manufacturing capacity for older essential medicines is "a valid thing," adding that Eli Lilly is "happy to…

US-Pharmakonzern Eli Lilly senkt Gewinnprognose wegen Abschreibungen

INDIANAPOLIS (dpa-AFX) - Der US-Pharmahersteller Eli Lilly hat wegen Abschreibungen auf einen Zukauf seine Gewinnerwartung…

Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer treatment deal

Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro soared in the first quarter.…

Eli Lilly posts strong Q1 results, but weight-loss drug sales disappoint

Eli Lilly on Thursday posted better-than-expected first quarter revenue and profit, although sales of its popular weight-loss drug, Zepbound, came…

Eli Lilly shares slide despite weight-loss drug boost as company trims 2025 profit outlook

Eli Lilly and Co (NYSE:LLY) shares fell as much as 7.7% at the open on Thursday after the drugmaker cut…

1 Beaten-Down Stock to Buy and Hold for 10 Years

Viking Therapeutics (NASDAQ: VKTX) was one of the hottest biotech stocks of 2024; its shares soared last year following excellent…

1 Beaten-Down Stock That Could Skyrocket By 321%, According to Wall Street

Equity markets have been volatile this year due to macroeconomic and geopolitical factors. Many of the worlds largest corporations havent…

Novo Nordisk strikes telehealth deals for obesity drug, following Eli Lilly

Novo is expanding its direct-to-consumer efforts around its obesity drug Wegovy, partnering with telehealth companies…

CEOs from Nividia, J&J and Eli Lilly to join Trumps "Invest in America" event at White House

Trumps tariffs threats have left the countrys status as the top global investment magnet in doubt.…

Trump to tout US investments from Nvidia, J&J, Hyundai, Toyota

CEOs and other executives from Nvidia , Johnson & Johnson , Toyota Motor , Eli Lilly and SoftBank Group are…

Trump to Tout US Investments From Nvidia, J&J, Hyundai, Toyota

By David Shepardson WASHINGTON (Reuters) -CEOs and other executives from Nvidia, Johnson & Johnson, Toyota Motor, Eli Lilly and SoftBank…

Nvidia, Eli Lilly Among CEOs to Tout US Investments With Trump

Chief executive officers from Nvidia Corp., Johnson & Johnson, Eli Lilly & Co., General Electric Co. and SoftBank Group Corp.…

Eli Lilly: Why Orforglipron Matters, A Lot

…